By Michael Susin

Haleon PLC said Thursday that 2022 pretax profit slightly fell on the back of increased costs, and that it has started to payout dividends.

The consumer-healthcare business, which was spun out of GSK PLC and is partly owned by Pfizer Inc., reported a pretax profit of 1.62 billion pounds ($1.95 billion) compared with GBP1.64 billion a year ago.

The group declared its first final dividend of 2.4 pence a share.

Revenue came in at GBP10.86 billion from GBP9.54 billion in 2021, while organic revenue growth rose to 9%, consisting of 4.3% volumes and 4.7% price mix.

Adjusted operating profit margin--which strips out exceptional and other one-off items--came in at 22.8%. Haleon expected to report slightly above its last year's margin of 22.8%.

For 2023, the company expects organic revenue growth to be in the range of 4% to 6%, while adjusted operating margin is forecast to be broadly flat after negative impacts of foreign exchange.

Write to Michael Susin at michael.susin@wsj.com

(END) Dow Jones Newswires

March 02, 2023 02:42 ET (07:42 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Haleon (LSE:HLN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Haleon Charts.
Haleon (LSE:HLN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Haleon Charts.